CLSI GP47 (R2019)

Management of Critical- and Significant-Risk Results, 1st Edition, GP47Ed1E, GP47ESEd1E

Clinical and Laboratory Standards Institute, 12/01/2015

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/12/2015

Pages:112

File Size:2 files , 7.2 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides current best practice recommendations for developing and implementing a policy and procedures for the identification, reporting, and management of critical- and significant-risk laboratory results. Emphasis is placed on management responsibilities such as development of the policy, the process, procedures, job descriptions, and monitoring systems that ensure effective reporting and compliance with regulatory requirements.

Executive Summary
This is an executive summary of GP47–Management of Critical- and Significant-Risk Results. It provides a compilation of all key recommendations from GP47 for policies and processes as well as risk management principles and information technology for the management of laboratory results that indicate critical or significant risk to patients.

More CLSI standard pdf

CLSI H48-A

CLSI H48-A

Determination of Factor Coagulant Activities; Approved Guideline

$90.00 $180.00

CLSI GP18A

CLSI GP18A

Laboratory Design : Approved Guideline (1997)

$143.00 $286.31

CLSI C42-A

CLSI C42-A

Erythrocyte Protoporphyrin Testing; Approved Guideline, C42AE

$113.00 $227.95

CLSI H26A

CLSI H26A

Performance Goals for the Internal Quality Control of Multichannel Hematology Analyzers; Approved Standard, H26-A

$135.00 $270.43